219 related articles for article (PubMed ID: 7922122)
1. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
Boger DL; Johnson DS; Yun W; Tarby CM
Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunit.
Boger DL; Zarrinmayeh H; Munk SA; Kitos PA; Suntornwat O
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1431-5. PubMed ID: 1847523
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
[TBL] [Abstract][Full Text] [Related]
5. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
Boger DL; Johnson DS
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
[TBL] [Abstract][Full Text] [Related]
6. CC-1065 CBI analogs: an example of enhancement of DNA alkylation efficiency through introduction of stabilizing electrostatic interactions.
Boger DL; Yun W; Han N; Johnson DS
Bioorg Med Chem; 1995 Jun; 3(6):611-21. PubMed ID: 7582940
[TBL] [Abstract][Full Text] [Related]
7. Demonstration and definition of the noncovalent binding selectivity of agents related to CC-1065 by an affinity cleavage agent: noncovalent binding coincidental with alkylation.
Boger DL; Zhou J; Cai H
Bioorg Med Chem; 1996 Jun; 4(6):859-67. PubMed ID: 8818235
[TBL] [Abstract][Full Text] [Related]
8. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA.
Lee CS; Sun D; Kizu R; Hurley LH
Chem Res Toxicol; 1991; 4(2):203-13. PubMed ID: 1782349
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a common molecular basis for sequence recognition of N3-guanine and N3-adenine DNA adducts involving the covalent bonding reaction of (+)-CC-1065.
Park HJ
Arch Pharm Res; 2002 Feb; 25(1):11-24. PubMed ID: 11885687
[TBL] [Abstract][Full Text] [Related]
10. CBI-CDPBO1 and CBI-CDPBI1: CC-1065 analogs containing deep-seated modifications in the DNA binding subunit.
Boger DL; Yun W; Cai H; Han N
Bioorg Med Chem; 1995 Jun; 3(6):761-7. PubMed ID: 7582954
[TBL] [Abstract][Full Text] [Related]
11. A noncovalent binding-translocation mechanism for site-specific CC-1065-DNA recognition.
Gunz D; Naegeli H
Biochem Pharmacol; 1996 Aug; 52(3):447-53. PubMed ID: 8687499
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional 1H and 31P NMR spectra and restrained molecular dynamics structure of a covalent CPI-CDPI2-oligodeoxyribonucleotide decamer complex.
Powers R; Gorenstein DG
Biochemistry; 1990 Oct; 29(42):9994-10008. PubMed ID: 2271635
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of a site-directed CC-1065-N3-adenine adduct within a 117 base pair DNA restriction fragment.
Needham-VanDevanter DR; Hurley LH
Biochemistry; 1986 Dec; 25(26):8430-6. PubMed ID: 3030397
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
[TBL] [Abstract][Full Text] [Related]
15. (+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting.
Ding ZM; Harshey RM; Hurley LH
Nucleic Acids Res; 1993 Sep; 21(18):4281-7. PubMed ID: 8414983
[TBL] [Abstract][Full Text] [Related]
16. Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity.
Reynolds VL; Molineux IJ; Kaplan DJ; Swenson DH; Hurley LH
Biochemistry; 1985 Oct; 24(22):6228-37. PubMed ID: 3002434
[TBL] [Abstract][Full Text] [Related]
17. CC-1065 bonding to intracellular and purified SV40 DNA: site specificity and functional effects.
McHugh MM; Woynarowski JM; Mitchell MA; Gawron LS; Weiland KL; Beerman TA
Biochemistry; 1994 Aug; 33(31):9158-68. PubMed ID: 8049219
[TBL] [Abstract][Full Text] [Related]
18. (+)-CC-1065 as a probe for intrinsic and protein-induced bending of DNA.
Hurley LH; Sun D
J Mol Recognit; 1994 Jun; 7(2):123-32. PubMed ID: 7826672
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
Boger DL; Hughes TV; Hedrick MP
J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
[TBL] [Abstract][Full Text] [Related]
20. CC-1065/duocarmycin and bleomycin A2 hybrid agents: lack of enhancement of DNA alkylation by attachment to noncomplementary DNA binding subunits.
Boger DL; Han N
Bioorg Med Chem; 1997 Feb; 5(2):233-43. PubMed ID: 9061188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
